Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab Luis Figuero-Pérez; Alejandro Olivares-Hernández; Roberto A. Escala-Cornejo; Eduardo Terán-Brage; Álvaro López-Gutiérrez; Juan J. Cruz-Hernández;

Colchicine: A potential therapeutic tool against COVID-19. Experience of 5 patients Giovanni Montealegre-Gómez; Edgar Garavito; Arley Gómez-López; Adriana Rojas-Villarraga; Rafael Parra-Medina;

The impact of COVID-19 and other factors on the usage status of the biologic drug therapies for rheumatoid arthritis: A study from Vietnam Hai-Binh Bui; Hong-Thinh Lai; Thanh-Lam Nguyen; Thuy-Duong Vu; Nhat-Le Bui; Van-Hung Nguyen; Thi-To-Chau Tran; Thi-Phuong-Thuy Nguyen; Thi-Ngoc-Lan Nguyen; Jaffar A. Al-Tawfiq; Dinh-Toi Chu;